World's Best Scientists 2026 revealed!

Shosaku Nomura publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Shosaku Nomura sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

The last bar groups every scientist with 1,796 publications or more.

Shosaku Nomura D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Shosaku Nomura sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

The last bar groups every scientist with 217 D-Index or more.

Overview

Shosaku Nomura is affiliated with Kansai Medical University in Japan and has a research focus primarily in the field of medicine, with a significant emphasis on oncology. Their work spans multiple subfields, including oncology, pulmonary and respiratory medicine, cancer research, surgery, and molecular biology.

Nomura's research topics include colorectal cancer treatments and studies, lung cancer treatments and mutations, gastric cancer management and outcomes, cancer genomics and diagnostics, lung cancer diagnosis and treatment, cancer immunotherapy and biomarkers, and lung cancer research studies.

Frequent coauthors collaborating with Nomura are Takayuki Yoshino, Akihiro Sato, Masashi Wakabayashi, Tomohiro Nishina, and Hiroya Taniguchi.

The recurring publication venues where Nomura's work appears include the Journal of Clinical Oncology, Annals of Oncology, Lung Cancer, Cancer Medicine, and ESMO Open.

Notable publications by Nomura include:

  • Regorafenib Plus Nivolumab in Patients With Advanced Gastric or Colorectal Cancer: An Open-Label, Dose-Escalation, and Dose-Expansion Phase Ib Trial (REGONIVO, EPOC1603), 2020, Journal of Clinical Oncology
  • Lenvatinib plus pembrolizumab in patients with advanced gastric cancer in the first-line or second-line setting (EPOC1706): an open-label, single-arm, phase 2 trial, 2020, The Lancet Oncology
  • Circulating tumor DNA-guided treatment with pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer: a phase 2 trial, 2021, Nature Medicine
  • Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial, 2023, The Lancet
  • Multicenter Phase I/II Trial of Napabucasin and Pembrolizumab in Patients with Metastatic Colorectal Cancer (EPOC1503/SCOOP Trial), 2020, Clinical Cancer Research

Best Publications

  • Targeted Disruption of Cbfa1 Results in a Complete Lack of Bone Formation owing to Maturational Arrest of Osteoblasts

    T Komori;H Yagi;S Nomura;A Yamaguchi

  • High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles

    Yasuhiko Miyazaki;Shosaku Nomura;Tetsuya Miyake;Hideo Kagawa

  • Measuring circulating cell-derived microparticles

    W. Jy;L. L. Horstman;J. J. Jimenez;Y. S. Ahn

  • Platelet-derived microparticles may influence the development of atherosclerosis in diabetes mellitus.

    Shosaku Nomura;Masahiko Suzuki;Kaoruko Katsura;Gui Lan Xie

  • Vandetanib in patients with previously treated RET-rearranged advanced non-small-cell lung cancer (LURET): an open-label, multicentre phase 2 trial

    Kiyotaka Yoh;Takashi Seto;Miyako Satouchi;Makoto Nishio

  • Expression of oxytocin receptor in human pregnant myometrium.

    T Kimura;M Takemura;S Nomura;T Nobunaga

  • Function and role of microparticles in various clinical settings.

    Shosaku Nomura;Yukio Ozaki;Yasuo Ikeda

  • Significance of chemokines and activated platelets in patients with diabetes.

    S. Nomura;A. Shouzu;S. Omoto;M. Nishikawa

  • In situ hybridization of bone matrix proteins in undecalcified adult rat bone sections.

    T Ikeda;S Nomura;A Yamaguchi;T Suda

  • NZW x BXSB)F1 mouse. A new animal model of idiopathic thrombocytopenic purpura.

    N Oyaizu;R Yasumizu;M Miyama-Inaba;S Nomura

  • Effects of pegylated recombinant human megakaryocyte growth and development factor in patients with idiopathic thrombocytopenic purpura

    Shosaku Nomura;Kazuo Dan;Tomomitsu Hotta;Kingo Fujimura

  • The effects of pitavastatin, eicosapentaenoic acid and combined therapy on platelet-derived microparticles and adiponectin in hyperlipidemic, diabetic patients

    Shosaku Nomura;Norihito Inami;Akira Shouzu;Seitarou Omoto

  • TAS-102 plus bevacizumab for patients with metastatic colorectal cancer refractory to standard therapies (C-TASK FORCE): an investigator-initiated, open-label, single-arm, multicentre, phase 1/2 study

    Yasutoshi Kuboki;Tomohiro Nishina;Eiji Shinozaki;Kentaro Yamazaki

  • Effect of a single injection of humanized anti-CD154 monoclonal antibody on the platelet-specific autoimmune response in patients with immune thrombocytopenic purpura.

    Masataka Kuwana;Shosaku Nomura;Kingo Fujimura;Toshiro Nagasawa

  • Is eradication therapy useful as the first line of treatment in Helicobacter pylori-positive idiopathic thrombocytopenic purpura? Analysis of 207 eradicated chronic ITP cases in Japan.

    Kingo Fujimura;Masataka Kuwana;Yoshiyuki Kurata;Masahiro Imamura

  • Prognostic impact of the mean platelet volume/platelet count ratio in terms of survival in advanced non-small cell lung cancer.

    Noriko Inagaki;Kayoko Kibata;Takeshi Tamaki;Toshiki Shimizu

  • Circulating tumor DNA-guided treatment with pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer: a phase 2 trial.

    Yoshiaki Nakamura;Wataru Okamoto;Takeshi Kato;Taito Esaki

  • Long-term outcome and prognostic factors of surgically treated thymic carcinoma: results of 306 cases from a Japanese Nationwide Database Study.

    Tomoyuki Hishida;Shogo Nomura;Motoki Yano;Hisao Asamura

  • Neutrophil-to-lymphocyte ratio as an early marker of outcomes in patients with advanced non-small-cell lung cancer treated with nivolumab

    Aya Nakaya;Takayasu Kurata;Hiroshige Yoshioka;Yuki Takeyasu

  • Effect of cilostazol on soluble adhesion molecules and platelet-derived microparticles in patients with diabetes.

    Shosaku Nomura;Akira Shouzu;Seitaro Omoto;Takashi Hayakawa

Frequent Co-Authors

Yuzuru Kanakura
Yuzuru Kanakura Osaka University
Yasuo Ikeda
Yasuo Ikeda Waseda University
Akifumi Takaori-Kondo
Akifumi Takaori-Kondo Kyoto University
Masataka Kuwana
Masataka Kuwana Nippon Medical School
Yukio Ozaki
Yukio Ozaki University of Yamanashi
Shigeru Chiba
Shigeru Chiba University of Tsukuba
Yutaka Yatomi
Yutaka Yatomi University of Tokyo
Tsuneyasu Kaisho
Tsuneyasu Kaisho Wakayama Medical University
Susumu Ikehara
Susumu Ikehara Kansai Medical University
Masafumi Taniwaki
Masafumi Taniwaki Kyoto Prefectural University of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative pathways and flexible online degrees can be a great option for those interested in healthcare careers beyond traditional medical school. Many students now choose online or accelerated programs to save time and balance their studies with work or family commitments.

Nurses looking to advance may consider online dnp programs without dissertation—ideal for those seeking leadership roles or advanced practice without the research component of traditional DNP degrees. Alternatively, those hoping to enter the workforce quickly can check out an lpn accelerated program to fast-track their journey to becoming a licensed practical nurse.

For nurses interested in specialized care, the shortest pmhnp program is an efficient way to become a Psychiatric Mental Health Nurse Practitioner and meet the growing mental health needs in the U.S.

If you are considering the business side of healthcare, pursuing a health care administration degree online opens doors to management and leadership positions in hospitals and clinics. These options offer flexible, accessible, and cost-effective ways to advance your healthcare career.

Best Scientists Citing Shosaku Nomura

Trending Scientists